PRIME MEMBER EXCLUSIVE | 3 Months Free Trial

Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
NEJM Interviews cover art

NEJM Interviews

NEJM Interviews

Written by: NEJM Group
Listen for free

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.Copyright 2026 Massachusetts Medical Society Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.

    NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.
    Jun 24 2026
    Stacie Dusetzina is a professor of health policy and of cancer research at the Vanderbilt University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina. Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? N Engl J Med 2026;394:2385-2387.
    Show More Show Less
    13 mins
  • NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States.

    NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States.
    Jun 17 2026
    Marcus Hughes is an assistant professor of psychiatry at the Yale School of Medicine and an attending psychiatrist at Yale New Haven Psychiatric Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Hughes. Psychedelic Therapies in the United States — Balancing State and Federal Oversight. N Engl J Med 2026;394:2281-2283. Y. Zisman-Ilani and R. Yehuda. Patient-Driven Care in Psychedelic Therapy. N Engl J Med 2026;394:2284-2286.
    Show More Show Less
    9 mins
  • NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress.

    NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress.
    Jun 10 2026
    Edward Ryan is the director of global infectious diseases at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.T. Ryan, F. Qadri, and J.A. Lynch. Global Cholera-Control Efforts — Progress and Remaining Challenges. N Engl J Med 2026;394:2177-2180.
    Show More Show Less
    12 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet